Cargando…

Plasma long noncoding RNAs PANDAR, FOXD2-AS1, and SMARCC2 as potential novel diagnostic biomarkers for gastric cancer

BACKGROUND: Gastric cancer is still a common cancer worldwide. Investigation of potential plasma biomarkers for gastric cancer diagnosis is essential for prevention strategies and early intervention for gastric cancer-control planning. OBJECTIVES: This study was aimed to explore the lncRNAs' pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ziwei, Sun, Yanfei, Liu, Rongfeng, Shi, Yanyan, Ding, Shigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613614/ https://www.ncbi.nlm.nih.gov/pubmed/31308753 http://dx.doi.org/10.2147/CMAR.S201935

Ejemplares similares

Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2017)

Long noncoding RNA PANDAR inhibits the development of lung cancer by regulating autophagy and apoptosis pathways
por: Zhang, Lan, et al.
Publicado: (2020)

Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer
por: Liu, Jun, et al.
Publicado: (2018)

Estimating gene regulatory networks with pandaR
por: Schlauch, Daniel, et al.
Publicado: (2017)

Pro-inflammatory activity of long noncoding RNA FOXD2-AS1 in Achilles tendinopathy
por: Ke, Xiaoting, et al.
Publicado: (2023)

Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells
por: Chen, Tao, et al.
Publicado: (2017)

Expanding the phenotype associated with SMARCC2 variants: a fetus with tetralogy of Fallot
por: Sun, Hairui, et al.
Publicado: (2022)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Circulating Serum Exosomal Long Non-Coding RNAs FOXD2-AS1, NRIR, and XLOC_009459 as Diagnostic Biomarkers for Colorectal Cancer
por: Yu, Miao, et al.
Publicado: (2021)

SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer
por: Wei, Zhengmao, et al.
Publicado: (2022)

Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2
por: Han, L, et al.
Publicado: (2015)

Identification of novel PANDAR protein interaction partners involved in splicing regulation
por: Pospiech, N., et al.
Publicado: (2018)

Regulatory roles of lncRNA PANDAR in breast cancer cell proliferation
por: Sun, Qinnuan, et al.
Publicado: (2021)

SMARCC1 expression is positively correlated with pathological grade and good prognosis in renal cell carcinoma
por: Wang, Gangmin, et al.
Publicado: (2021)

Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
por: Yang, Lan, et al.
Publicado: (2018)

FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients
por: Li, Jing, et al.
Publicado: (2016)

FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination
por: Liu, Songbai, et al.
Publicado: (2023)

Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation
por: Li, Rui, et al.
Publicado: (2020)

Correction for: FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination
por: Liu, Songbai, et al.
Publicado: (2023)

FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
por: Wu, Qiong, et al.
Publicado: (2020)

Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation
por: Lv, Xuyang, et al.
Publicado: (2021)

Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer
por: Andersen, C L, et al.
Publicado: (2009)

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
por: Iwagami, Y, et al.
Publicado: (2013)

A heterotrimeric SMARCB1–SMARCC2 subcomplex is required for the assembly and tumor suppression function of the BAF chromatin-remodeling complex
por: Chen, Guidong, et al.
Publicado: (2020)

Long noncoding RNA FOXD2‐AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR‐206/MAP3K1 axis
por: Hu, Wei, et al.
Publicado: (2020)

Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor
por: Dou, Xiaoqing, et al.
Publicado: (2020)

Knockdown of lncRNA-PANDAR suppresses the proliferation, cell cycle and promotes apoptosis in thyroid cancer cells
por: Li, Zhirong, et al.
Publicado: (2017)

LncRNA-PANDAR regulates the progression of thyroid carcinoma by targeting miR-637/KLK4
por: Qing, Yi, et al.
Publicado: (2021)

The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
por: Wang, Hao, et al.
Publicado: (2018)

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
por: Qiu, Shijie, et al.
Publicado: (2021)

SMARCC2 combined with c-Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β-catenin signaling pathway
por: Li, Chiyang, et al.
Publicado: (2021)

SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma
por: Li, Chiyang, et al.
Publicado: (2022)

SIRT1-targeted miR-543 autophagy inhibition and epithelial–mesenchymal transition promotion in Helicobacter pylori CagA-associated gastric cancer
por: Shi, Yanyan, et al.
Publicado: (2019)

Long Noncoding RNA (lncRNA) FOXD2-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Regulating MiR-185/AKT Axis
por: Chen, Zheng, et al.
Publicado: (2019)

Retraction: Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging microRNA-760 and upregulating hepatoma-derived growth factor
por: Frontiers Editorial Office,
Publicado: (2023)

The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer
por: Ke, Dong, et al.
Publicado: (2017)

FOXD3 Regulates VISTA Expression in Melanoma
por: Rosenbaum, Sheera R., et al.
Publicado: (2020)

Molecular mechanisms of long noncoding RNAs on gastric cancer
por: Li, Tianwen, et al.
Publicado: (2016)

Noncoding RNAs in gastric cancer: implications for drug resistance
por: Wei, Ling, et al.
Publicado: (2020)

Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected
por: Bure, Irina V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_joc4kotnv45ui36hilh06ems0a